imatinib mesylate has been researched along with Adenopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherix, S; Digklia, A; Dolcan, A; Koulouris, P; Matter, M; Omoumi, P; Papadopoulos, S; Royer-Chardon, C; Tsoumakidou, G | 1 |
1 other study(ies) available for imatinib mesylate and Adenopathy
| Article | Year |
|---|---|
Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients.
Topics: Drug-Related Side Effects and Adverse Reactions; Fibromatosis, Aggressive; Humans; Imatinib Mesylate; Lymphadenopathy; Protein Kinase Inhibitors | 2022 |